For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251128:nRSb5211Ja&default-theme=true
RNS Number : 5211J Barclays Bank PLC 28 November 2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, SOUTH
AFRICA, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WOULD BE
UNLAWFUL.
28 November 2025
Shawbrook Group plc
Post-Stabilisation Period Announcement
Further to the pre-stabilisation period announcement dated 30 October 2025,
Barclays Capital Securities Limited (Contact: Ben Newmark; Telephone: +44 20
3134 8574) hereby gives notice that the Stabilising Manager named below and
its affiliates undertook stabilisation in accordance with the relevant
provisions of the Market Abuse Regulation (EU) No 596/2014 of the European
Parliament and of the Council (as it forms part of retained EU law in the
United Kingdom by virtue of the European Union (Withdrawal) Act 2018) and
Commission Delegated Regulation (EU) 2016/1052 (as it forms part of retained
EU law as defined in the European Union (Withdrawal) Act 2018).
The securities
Issuer Shawbrook Group plc
Securities Ordinary Shares of £0.005 pence each
ISIN GB00BV9DPV21
Offering Size 94,007,050 Ordinary Shares (excluding the over-allotment option)
Description Initial Public Offering of Ordinary Shares
Offer price 370 pence per Ordinary Share
Stabilising Manager Barclays Capital Securities Limited, 1 Churchill Place, London, E14 5HP,
United Kingdom
Stabilisation period From 30 October 2025 to 28 November 2025
Stabilisation last occurred on 24 November 2025
Stabilisation trading venue(s) London Stock Exchange
Stabilisation transactions
For each of the dates during which stabilisation transactions were carried
out, the price range was as follows:
Execution Date Lowest Price Highest Price Trading Venue
5 November 2025 370.00 370.00 London Stock Exchange
6 November 2025 370.00 370.00 London Stock Exchange
18 November 2025 370.00 370.00 London Stock Exchange
19 November 2025 370.00 370.00 London Stock Exchange
20 November 2025 369.00 370.00 London Stock Exchange
21 November 2025 366.00 366.00 London Stock Exchange
24 November 2025 366.00 366.00 London Stock Exchange
Barclays Capital Securities Limited, acting as the stabilising manager, has
today given notice to exercise the over-allotment option (the "Over-allotment
Option") granted by Marlin Bidco Limited in respect of 13,673,547 ordinary
shares in Shawbrook at the offer price of 370 pence per share.
Giving effect to the exercise of the Over-allotment Option, the final size of
the Offer is approximately £398 million (approximately 108 million ordinary
shares), representing approximately 21 per cent. of the ordinary shares in
Shawbrook.
Important legal information
This announcement is for information purposes only and does not constitute an
invitation or offer to underwrite, subscribe for or otherwise acquire or
dispose of any securities of the Issuer in any jurisdiction.
In the United Kingdom, this announcement is being distributed only to, and is
directed only at, persons who: (A) (i) are "investment professionals"
specified in Article 19(5) of the Financial Services and Markets Act
(Financial Promotion) Order 2005 (the "Order") and/or (ii) fall within Article
49(2)(a) to (d) of the Order (and only where the conditions contained in those
Articles have been, or will at the relevant time be, satisfied); and (B) are
"qualified investors" within the meaning of Article 2 of the Prospectus
Regulation (Regulation (EU) 2017/1129) as it forms part of retained EU law as
defined in the EU (Withdrawal) Act 2018 (all such persons together being
referred to as "Relevant Persons").
In any member state of the European Economic Area ("EEA") (each, a "Relevant
Member State"), this announcement and any offer if made subsequently is, and
will be, directed only at persons who are "qualified investors" ("Qualified
Investors") within the meaning of the Prospectus Regulation (Regulation (EU)
2017/1129).
This announcement must not be acted on or relied on (i) in the United Kingdom,
by persons who are not Relevant Persons, and (ii) in any member state of the
EEA, by persons who are not Qualified Investors. Any investment or investment
activity to which this announcement relates is available only to: (i) in the
United Kingdom, Relevant Persons; and (ii) in any member state of the EEA,
Qualified Investors, and will be engaged in only with such persons.
This announcement does not constitute, or form part of, an offer to sell, or a
solicitation of an offer to purchase any securities in the United States or
any other jurisdiction. The securities referred to herein have not been and
will not be registered under the U.S. Securities Act of 1933 as amended (the
"Securities Act") and may not be offered or sold in the United States except
to "qualified institutional buyers" as defined in, and in reliance on, Rule
144A under the Securities Act or another exemption from, or transaction not
subject to, the registration requirements of the Securities Act. All offers
and sales of securities outside of the United States will be made in reliance
on, and in compliance with, Regulation S under the Securities Act. There is no
intention to register any securities referred to herein in the United States
or to make a public offering of the securities in the United States.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END STAFEEFWAEISEFF
Copyright 2019 Regulatory News Service, all rights reserved